Iodine quantification with dual-energy CT: Phantom study and preliminary experience with VX2 residual tumour in rabbits after radiofrequency ablation

British Journal of Radiology

Volumn 86, Issue 1029, 2013, Pages

  Li, Y ^a   Shi, G ^a   Wang, S ^a   Wu, R ^b  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b SIEMENS LTD   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE; IOPROMIDE; DIAGNOSTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; CARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DUAL ENERGY COMPUTER ASSISTED TOMOGRAPHY; HISTOPATHOLOGY; LIVER CELL CARCINOMA; MALE; NONHUMAN; PORTAL VEIN; RABBIT; RADIOFREQUENCY ABLATION; RADIOLOGY PHANTOM; TREATMENT RESPONSE; TUMOR DIFFERENTIATION; ANIMAL; CATHETER ABLATION; DISEASE MODEL; FEMALE; IMAGE QUALITY; LIVER TUMOR; METHODOLOGY; MINIMAL RESIDUAL DISEASE; RADIOGRAPHY;

ANIMALS; CATHETER ABLATION; DISEASE MODELS, ANIMAL; FEMALE; IODINE; LIVER NEOPLASMS, EXPERIMENTAL; NEOPLASM, RESIDUAL; PHANTOMS, IMAGING; RABBITS; RADIOGRAPHY, DUAL-ENERGY SCANNED PROJECTION; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84882935172     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr.20130143     Document Type: Article

References (41)

1. Tateishi R, Shiina S, Teratani T, Obi S, Sato S, Koike Y, et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 2005;103: 1201-9. doi: 10.1002/cncr.20892 (Pubitemid 40328091)
2. Lee MW, Kim YJ, Park SW, Hwang JH, Jung SI, Jeon HJ, et al. Percutaneous radiofrequency ablation of small hepatocellular carcinoma invisible on both ultrasonography and unenhanced CT: a preliminary study of combined treatment with transarterial chemoembolisation. Br J Radiol 2009;82: 908-15.
3. Wood BJ, Ramkaransingh JR, Fojo T, Walther MM, Libutti SK. Percutaneous tumor ablation with radiofrequency. Cancer 2002;94:443-51. doi: 10.1002/cncr.10234 (Pubitemid 34081375)
4. Montella L, Addeo R, Caraglia M, Faiola V, Guarrasi R, Vincenzi B, et al. Vascular endothelial growth factor monitoring in advanced hepatocellular carcinoma patients treated with radiofrequency ablation plus octreotide: a single center experience. Oncol Rep 2008;20:385-90.
5. Choi H, Loyer EM, DuBrow RA, Kaur H, David CL, Huang S, et al. Radio-frequency ablation of liver tumors: assessment of therapeutic response and complications. Radiographics 2001;21:S41-54.
6. Dromain C, de Baere T, Elias D, Kuoch V, Ducreux M, Boige V, et al. Hepatic tumors treated with percutaneous radio-frequency ablation: CT and MR imaging follow-up. Radiology 2002;223: 255-62. (Pubitemid 34258217)
7. Raman SS, Lu DSK, Vodopich DJ, Sayre J, Lassman C. Creation of radiofrequency lesions in a porcine model: correlation with sonography, CT, and histopathology. AJR Am J Roentgenol 2000;175:1253-8. doi: 10.2214/ajr.175.5. 1751253
8. Goldberg SN, Charboneau JW, Dodd GD 3rd, Dupuy DE, Gervais DA, Gillams AR, et al. Image-guided tumor ablation: proposal for standardization of terms and reporting criteria. Radiology 2003;228:335-45. doi: 10.1148/radiol. 2282021787 (Pubitemid 36910070)
9. Hiraoka A, Hirooka M, Koizumi Y, Hidaka S, Uehara T, Ichikawa S, et al. Modified technique for determining therapeutic response to radiofrequency ablation therapy for hepatocellular carcinoma using US-volume system. Oncol Rep 2010;23:493-7.
10. Avril N. 18F-FDG PET after radiofrequency ablation: is timing everything? J Nucl Med 2006:47:1235-7. (Pubitemid 47544872)
11. Kubota K. From tumor biology to clinical PET: a review of positron emission tomography (PET) in oncology. Ann Nucl Med 2001;15:471-86. (Pubitemid 34131944)
12. Travaini LL, Trifirò G, Ravasi L, Monfardini L, Vigna PD, Bonomo G, et al. Role of [18F] FDG-PET/CT after radiofrequency ablation of liver metastases: preliminary results. Eur J Nucl Med Mol Imaging 2008;35:1316-22. doi: 10.1007/s00259-008- 0748-7
13. Chandarana H, Megibow AJ, Cohen BA, Srinivasan R, Kim D, Leidecker C, et al. Iodine quantification with dual-energy CT: phantom study and preliminary experience with renal masses. AJR Am J Roentgenol 2011;196:W693-700. doi: 10.2214/AJR.10.5541
14. Graser A, Johnson TR, Chandarana H, Macari M. Dual energy CT: preliminary observations and potential clinical applications in the abdomen. Eur Radiol 2009;19:13-23. doi: 10.1007/s00330-008-1122-7
15. Fletcher JG, Takahashi N, Hartman R, Guimaraes L, Huprich JE, Hough DM, et al. Dual-energy and dual-source CT: is there a role in the abdomen and pelvis? Radiol Clin North Am 2009;47:41-57. doi: 10.1016/j. rcl.2008.10.003
16. Holmes DR 3rd, Fletcher JG, Apel A, Huprich JE, Siddiki H, Hough DM, et al. Evaluation of non-linear blending in dualenergy computed tomography. Eur J Radiol 2008;68:409-13. doi: 10.1016/j. ejrad.2008.09.017
17. Behrendt FF, Schmidt B, Plumhans C, Keil S, Woodruff SG, Ackermann D, et al. Image fusion in dual energy computed tomography: effect on contrast enhancement, signal-to-noise ratio and image quality in computed tomography angiography. Invest Radiol 2009;44:1-6. doi: 10.1097/RLI.0b013e31818c3d4b
18. Lee SH, Lee JM, Kim KW, Klotz E, Kim SH, Lee JY, et al. Dual-energy computed tomography to assess tumor response to hepatic radiofrequency ablation: potential diagnostic value of virtual noncontrast images and iodine maps. Invest Radiol 2011;46:77-84. doi: 10.1097/RLI.0b013e3181f23fcd
19. Chae EJ, Song JW, Seo JB, Krauss B, Jang YM, Song KS. Clinical utility of dual-energy CT in the evaluation of solitary pulmonary nodules: initial experience. Radiology 2008;249: 671-81. doi: 10.1148/radiol.2492071956
20. Gupta RT, Ho LM, Marin D, Boll DT, Barnhart HX, Nelson RC. Dual-energy CT for the characterization of adrenal nodules: initial experience. AJR Am J Roentgenol 2010;194:1479-83. doi: 10.2214/AJR.09.3476
21. Zhang LJ, Zhao YE, Wu SY, Yeh BM, Zhou CS, Hu XB, et al. Pulmonary embolism detection with dual-energy CT: experimental study of dual-source CT in rabbits. Radiology 2009; 252:61-70. doi: 10.1148/radiol.2521081682
22. Zhang LJ, Wu S, Wang M, Lu L, Chen B, Jin L, et al. Quantitative dual energy CT measurements in rabbit VX2 liver tumors: comparison to perfusion CT measurements and histopathological findings. Eur J Radiol 2012;81:1766-75. doi: 10.1016/j. ejrad.2011.06.057
23. Zhang LJ, Yang GF, Zhao YE, Zhou CS, Lu GM. Detection of pulmonary embolism using dual-energy computed tomography and correlation with cardiovascular measurements: a preliminary study. Acta Radiol 2009;50:892-901. doi: 10.1080/02841850903095393
24. Li Q, Du J, Yu M, He G, Luo W, Li H, et al. Transmission electron microscopy of VX2 liver tumors after high-intensity focused ultrasound ablation enhanced with SonoVue. Adv Ther 2009;26:117-25. doi: 10.1007/s12325-008-0126-7
25. Liang XM, Tang GY, Cheng YS, Zhou B. Evaluation of a rabbit rectal VX2 carcinoma model using computed tomography and magnetic resonance imaging. World J Gastroenterol 2009;15:2139-44.
26. Kim KW, Lee JM, Kim JH, Klotz E, Kim HC, Han JK, et al. CT color mapping of the arterial enhancement fraction of VX2 carcinoma implanted in rabbit liver: comparison with perfusion CT. AJR Am J Roentgenol 2011;196:102-8. doi: 10.2214/AJR.09.3971
27. Petersilka M, Bruder H, Krauss B, Stierstorfer K, Flohr TG. Technical principles of dual source CT. Eur J Radiol 2008;68:362-8. doi: 10.1016/j.ejrad.2008.08.013
28. Solbiati L, Goldberg SN, Ierace T, Livraghi T, Meloni F, Dellanoce M, et al. Hepatic metastases: percutaneous radio-frequency ablation with cooled-tip electrodes. Radiology 1997;205:367-73.
29. Goldberg SN, Grassi CJ, Cardella JF, Charboneau JW, Dodd GD III, Dupuy DE, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology 2005;235:728-39. (Pubitemid 40695866)
30. Lim HK, Choi D, Lee WJ, Kim SH, Lee SJ, Jang HJ, et al. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: evaluation with follow-up multiphase helical CT. Radiology 2001;221:447-54. (Pubitemid 33043430)
31. Antoch G, Vogt FM, Veit P, Freudenberg LS, Blechschmid N, Dirsch O, et al. Assessment of liver tissue after radiofrequency ablation: findings with different imaging procedures. J Nucl Med 2005;46:520-5. (Pubitemid 43093165)
32. Kim CK, Choi D, Lim HK, Kim SH, Lee WJ, Kim MJ, et al. Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging. Eur J Radiol 2005;56:66-73. (Pubitemid 41316489)
33. Zhuang H, Pourdehnad M, Lambright ES, Yamamoto AJ, Lanuti M, Li P, et al. Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes. J Nucl Med 2001;42:1412-170.
34. Beer AJ, Haubner R, Goebel M, Luderschmidt S, Spilker ME, Wester HJ, et al. Biodistribution and pharmaco kinetics of the alphavbeta3-selective tracer 18F-galacto-RGD in cancer patients. J Nucl Med. 2005;46:1333-41. (Pubitemid 43733484)
35. Platt JF, Reige KA, Ellis JH. Aortic enhancement during abdominal CT angiography: correlation with test injections, flow rates, and patient demographics. AJR Am J Roentgenol 1999;172: 53-6. doi: 10.2214/ajr.172.1.9888738 (Pubitemid 29028429)
36. Zatz LM. The effect of the kVp level on EMI values. Radiology 1976;119:683-8.
37. Apfaltrer P, Meyer M, Meier C, Henzler T, Barraza JM Jr, Dinter DJ, et al. Contrast-enhanced dual-energy CT of gastrointestinal stromal tumors is iodinerelated attenuation a potential indicator of tumor response? Invest Radiol 2012;47: 65-70. doi: 10.1097/RLI.0b013e31823003d2
38. Schmid-Bindert G, Henzler T, Chu TQ, Meyer M, Nance JW, Schoepf UJ, et al. Functional imaging of lung cancer using dual energy CT: how does iodine related attenuation correlate with standardized uptake value of 18FDG-PET-CT? Eur Radiol 2012;22:93-103. doi: 10.1007/s00330-011-2230-3
39. Graser A, Johnson TR, Hecht EM, Becker CR, Leidecker C, Staehler M, et al. Dual-energy CT in patients suspected of having renal masses: can virtual nonenhanced images replace true nonenhanced images? Radiology 2009; 252:433-40. doi: 10.1148/radiol.2522080557
40. Abramovitch R, Marikovsky M, Meir G, Neeman M. Stimulation of tumour angiogenesis by proximal wounds: spatial and temporal analysis by MRI. Br J Cancer 1998;77:440-7. (Pubitemid 28044049)
41. Anderson NG, Butler AP, Scott NJ, Cook NJ, Butzer JS, Schleich N, et al. Spectroscopic (multi-energy) CT distinguishes iodine and barium contrast material in MICE. Eur Radiol 2010;20:2126-34. doi: 10.1007/s00330-010-1768-9